Report cover image

Guerbet SA (GBT) - Product Pipeline Analysis, 2022 Update

Publisher GlobalData
Published Dec 16, 2022
Length 47 Pages
SKU # GBDT17580980

Description

Summary

Guerbet SA (Guerbet) is a manufacturer of contrast agents. The company provides a wide range of imaging products, solutions, and services for Computed Tomography (CT)/Cath Lab examinations, magnetic resonance imaging (MRI), and interventional imaging. CT/Cath Lab contrast agents consist of iodinated active ingredients, and few examinations of the digestive tract use barium-based products. MRI imaging uses gadolinium complexes. Guerbet has a presence in Europe, Asia, and North and South America. The company offers products directly through its sales structure, distributors, and license holders. Guerbet is headquartered in Villepinte, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Guerbet SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

47 Pages
Guerbet SA Company Overview
Guerbet SA Company Snapshot
Guerbet SA Pipeline Products and Ongoing Clinical Trials Overview
Guerbet SA – Pipeline Analysis Overview
Business Description
Guerbet SA - Key Facts
Guerbet SA - Major Products and Services
Guerbet SA Pipeline Products by Development Stage
Guerbet SA Pipeline Products Overview
AirFLO2
AirFLO2 Product Overview
Contrast Media Injector
Contrast Media Injector Product Overview
Contrast&Care 3.0
Contrast&Care 3.0 Product Overview
Elucirem
Elucirem Product Overview
Microguidewire
Microguidewire Product Overview
Next Generation Optistar
Next Generation Optistar Product Overview
Next Generation Urologic Imagery System
Next Generation Urologic Imagery System Product Overview
Optivantage - Multi-Use Injector
Optivantage - Multi-Use Injector Product Overview
Optivantage - Multi-Use Injector V2
Optivantage - Multi-Use Injector V2 Product Overview
SeQure
SeQure Product Overview
Tumor Biomarker
Tumor Biomarker Product Overview
Ultra Hi-Flow Microcatheter
Ultra Hi-Flow Microcatheter Product Overview
Ultra-Low Profile Microcatheter
Ultra-Low Profile Microcatheter Product Overview
Watson Imaging Care Advisor System
Watson Imaging Care Advisor System Product Overview
Guerbet SA - Key Competitors
Guerbet SA - Key Employees
Guerbet SA - Key Employee Biographies
Guerbet SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Guerbet SA, Recent Developments
Oct 20, 2022: Guerbet Revenue at September 30, 2022
Apr 21, 2022: Guerbet: Q1 2022 revenue
Mar 23, 2022: Guerbet Announces 2021 annual results
Jan 12, 2022: Guerbet Announces Appointment of Jared Houk as Commercial Vice President for North America
Oct 21, 2021: Guerbet Revenue at September 30, 2021
Sep 22, 2021: Guerbet Announces consolidated results for the first half of 2021
Mar 24, 2021: Guerbet announces 2020 annual results
Jul 15, 2020: Guerbet optimizes its Industrial Network / Sale of the Montreal pharmaceutical site
Feb 26, 2020: Guerbet to showcase next generation digital solutions at HIMSS20
Feb 13, 2020: Guerbet: 2019 revenue
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Guerbet SA Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Guerbet SA Pipeline Products by Equipment Type
Table 3: Guerbet SA Pipeline Products by Indication
Table 4: Guerbet SA, Key Facts
Table 5: Guerbet SA, Major Products and Services
Table 6: Guerbet SA Number of Pipeline Products by Development Stage
Table 7: Guerbet SA Pipeline Products Summary by Development Stage
Table 8: AirFLO2 - Product Status
Table 9: AirFLO2 - Product Description
Table 10: Contrast Media Injector - Product Status
Table 11: Contrast Media Injector - Product Description
Table 12: Contrast&Care 3.0 - Product Status
Table 13: Contrast&Care 3.0 - Product Description
Table 14: Elucirem - Product Status
Table 15: Elucirem - Product Description
Table 16: Microguidewire - Product Status
Table 17: Microguidewire - Product Description
Table 18: Next Generation Optistar - Product Status
Table 19: Next Generation Optistar - Product Description
Table 20: Next Generation Urologic Imagery System - Product Status
Table 21: Next Generation Urologic Imagery System - Product Description
Table 22: Optivantage - Multi-Use Injector - Product Status
Table 23: Optivantage - Multi-Use Injector - Product Description
Table 24: Optivantage - Multi-Use Injector V2 - Product Status
Table 25: Optivantage - Multi-Use Injector V2 - Product Description
Table 26: SeQure - Product Status
Table 27: SeQure - Product Description
Table 28: Tumor Biomarker - Product Status
Table 29: Tumor Biomarker - Product Description
Table 30: Ultra Hi-Flow Microcatheter - Product Status
Table 31: Ultra Hi-Flow Microcatheter - Product Description
Table 32: Ultra-Low Profile Microcatheter - Product Status
Table 33: Ultra-Low Profile Microcatheter - Product Description
Table 34: Watson Imaging Care Advisor System - Product Status
Table 35: Watson Imaging Care Advisor System - Product Description
Table 36: Guerbet SA, Key Employees
Table 37: Guerbet SA, Key Employee Biographies
Table 38: Guerbet SA, Other Locations
Table 39: Guerbet SA, Subsidiaries
Table 40: Glossary
List of Figures
Figure 1: Guerbet SA Pipeline Products by Equipment Type
Figure 2: Guerbet SA Pipeline Products by Development Stage

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us